Senolytic Therapy as a Preventive Strategy for Spine Degeneration and Pain.

Saber Ghazizadeh, Hosni Cherif, Matthew Mannarino, Juiena Sagir, Magali Millecamps, Jean A Ouellet, Laura S Stone, Lisbet Haglund

Department of Surgery, Orthopaedic Research Lab, McGill University, Montreal, Quebec, Canada.Department of Surgery, Orthopaedic Research Lab, McGill University, Montreal, Quebec, Canada. · pubmed

Paper

Abstract

Cellular senescence drives inflammation and tissue breakdown and is a key hallmark of aging. The accumulation of senescent cells is strongly linked to the degeneration of spinal tissues and back pain. Here, we show that administration of the senolytic agents, o-vanillin and RG-7112, prevents the development of pain-related behavior in sparc

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that senolytic agents can prevent pain-related behavior associated with spinal degeneration. This research is relevant as it addresses the accumulation of senescent cells, which is a root cause of aging and age-related degeneration, potentially offering a preventive strategy for age-related diseases.

Author of this paper? Send a correction.